Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Bunker

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Medicinal Chemistry|December 13, 2006
Cyclopentanone ring-cleaved pleuromutilin derivativesDane M Springer, Amy Bunker, Bing-Yu Luh, et al.
Journal of Medicinal Chemistry|February 7, 2008
Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisJie Jack Li, Joe Nahra, Adam R Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2007
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitorsMakonen Belema, Amy Bunker, Van N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of painChristopher Deur, Arun K Agrawal, Heidi Baum, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Medicinal Chemistry|December 13, 2006
Cyclopentanone ring-cleaved pleuromutilin derivativesDane M Springer, Amy Bunker, Bing-Yu Luh, et al.
Journal of Medicinal Chemistry|February 7, 2008
Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisJie Jack Li, Joe Nahra, Adam R Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2007
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitorsMakonen Belema, Amy Bunker, Van N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of painChristopher Deur, Arun K Agrawal, Heidi Baum, et al.
Pageof 1